Testing effectiveness (Phase 2)Study completedNCT00698763
What this trial is testing
Effects of Oral Levosimendan on Ambulatory Electrocardiographic Variables
Who this might be right for
Transient Ischemic AttackStroke
Orion Corporation, Orion Pharma 32